What's new

Human medicines European public assessment report (EPAR): Febuxostat Krka, febuxostat, Date of authorisation: 28/03/2019, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Febuxostat Krka, febuxostat, Date of authorisation: 28/03/2019, Revision: 7, Status: Authorised

Mar 27, 2025 - 16:45
 0
Human medicines European public assessment report (EPAR): Febuxostat Krka, febuxostat, Date of authorisation: 28/03/2019, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Febuxostat Krka, febuxostat, Date of authorisation: 28/03/2019, Revision: 7, Status: Authorised
Read More

Tags:

Previous Article

Detroit automaker shares fall after Trump's tariff announcement

Next Article

Human medicines European public assessment report (EPAR): Cresemba, isavuconazol...

Related Posts

PSUSA/00002229/202404

PSUSA/00002229/202404

Feb 9, 2025  0

Agenda of the CHMP meeting 24-27 March 2025

Mar 24, 2025  0

Checklist for the submission of Type IA and Type IB (wi...

Feb 18, 2025  0